Pediarix DTaP-HepB-IPV
Selected indexed studies
- New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel). (Ann Pharmacother, 2010) [PMID:20197476]
- Use of combination vaccines is associated with improved coverage rates. (Pediatr Infect Dis J, 2007) [PMID:17529866]
- FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined, (PEDIARIX) for use in infants. (MMWR Morb Mortal Wkly Rep, 2003) [PMID:12653460]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel). (2010) pubmed
- Use of combination vaccines is associated with improved coverage rates. (2007) pubmed
- FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined, (PEDIARIX) for use in infants. (2003) pubmed
- Societal impact of combination vaccines: experiences of physicians, nurses, and parents. (2008) pubmed
- Clinical evaluation of a DTaP-HepB-IPV combined vaccine. (2003) pubmed
- Pricing strategies for combination pediatric vaccines and their impact on revenue: Pediarix or Pentacel? (2010) pubmed